Commentary
Commentary
GLP-1 RA Therapy for Alcohol Use Disorder?
Similar to what we see in obesity, these medications may work by affecting what we call reward processing, or the seeking for addictive drugs,...
Commentary
Depiction of Cancer in Movies: Not an Accurate Portrayal
“The point of this was not to tell Hollywood how to make their movies but to have the oncology community recognize that if their patients or the...
Commentary
Delayed Bleeding: The Silent Risk for Seniors
The way that it did change my care was to give good return precautions to patients, to make sure they have somebody with them to say, “Hey,...
Commentary
The Wellness Industry: Financially Toxic, Says Ethicist
The money coming out of people’s pockets for wellness products could be used for the payment of things that we know work.
Latest News
SURMOUNT-OSA Results: ‘Impressive’ in Improving Sleep Apnea
Doctors discuss the SURMOUNT-OSA study that led to a mean reduction in AHI of over 60%.
Commentary
Are Beta-Blockers Needed Post MI? No, Even After the ABYSS Trial
ABYSS is consistent with REDUCE-AMI, says doctor; stopping beta-blockers at 1 year did not increase death, MI, or stroke.
Commentary
What Are the Best Supplements for Patients With Kidney Disease? A Few Stand Out
A dietitian provides advice on the best supplements for kidney disease, including fish oil, probiotics, and vitamin D.
Commentary
Part of Taking a Good (Human) Patient History Includes Asking About Pet Vaccinations
Following trends in humans, rates of vaccination in pets have decreased in recent years.
Opinion
The Prohibitive Price Tag
The guidelines, in essence, are useful, but only apply to a perfect world where drug cost doesn’t matter.
Commentary
Promoting a Weight-Inclusive Approach to Treat Obesity
There is a common denominator: Help patients live healthy, long lives.
Commentary
Gabapentin: The Hope, the Harm, the Myth, the Reality
The drug has a surprising number of off-label uses, some with no evidence of efficacy.